Research Advances of Immunotherapy of Exosome PD-L1 
in Non-small Cell Lung Cancer

Research Advances of Immunotherapy of Exosome PD-L1 
in Non-small Cell Lung Cancer

Cancer immunotherapy is increasingly popular in the field of cancer treatment, and related research is emerging. For patients with non-small cell lung cancer (NSCLC), in recent years, immune checkpoint inhibitors (ICIs) represented by programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD...

Full description

Bibliographic Details
Main Authors: Na WANG, Xia SONG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2022-09-01
Series:Chinese Journal of Lung Cancer
Subjects:
exosome
pd-l1
lung neoplasms
immunotherapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.33

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.33

Similar Items